SUMMARY We investigated the hemodynamics of the greater and lesser circulation in 35 patients with primary hypertension, as well as the effects of calcium-channel blockade, to test whether a common factor may account for the excessive vascular resistance in the two circuits and whether intracellular calcium concentration ([Ca++]i) may be involved. We proved that (1) elevated pulmonary arteriolar resistance (PAR) is not related to pulmonary blood flow and volume, pleural pressure, arterial oxygen or carbon dioxide tension and pH, left ventricular filling pressure and function; (2) systemic vascular resistance (SVR) significantly correlates with PAR; (3) calcium-channel blockade with nifedipine reduces systemic and pulmonary arterial pressures toward normal and significantly lowers both SVR and PAR; (4) the percent decrease in vascular resistance after nifedipine is related to the baseline level of resistance in both the greater and the lesser circulations.
SUMMARY We investigated the hemodynamics of the greater and lesser circulation in 35 patients with primary hypertension, as well as the effects of calcium-channel blockade, to test whether a common factor may account for the excessive vascular resistance in the two circuits and whether intracellular calcium concentration ([Ca++]i) may be involved. We proved that (1) elevated pulmonary arteriolar resistance (PAR) is not related to pulmonary blood flow and volume, pleural pressure, arterial oxygen or carbon dioxide tension and pH, left ventricular filling pressure and function; (2) systemic vascular resistance (SVR) significantly correlates with PAR; (3) calcium-channel blockade with nifedipine reduces systemic and pulmonary arterial pressures toward normal and significantly lowers both SVR and PAR; (4) the percent decrease in vascular resistance after nifedipine is related to the baseline level of resistance in both the greater and the lesser circulations.
Failure of the mechanisms currently indicated as responsible for pulmonary vasoconstriction to explain convincingly the increased PAR, the correlation between SVR and PAR, as well as the qualitatively similar response to calcium-channel blockade suggest that a common factor produces vasoconstriction in the two circuits. A pathogenetic role of a primary disorder in [Ca++] i cannot be excluded, but remains to be proved.
BLOOD PRESSURE elevation in most patients with chronic hypertension is associated with increased peripheral vascular resistance, which is due in part to abnormal constriction of the resistance vessels.' For a time, the autoregulatory theory4 was popular. Interest has now focused on the hypothesis that an excessive intracellular calcium-ion concentration ([Ca++] For intracellular sodium to be raised, the delicate mechanisms that are located in the membrane and regulate the sodium and potassium content of the cell must be disturbed. Several investigators have described a defect in ion transport across the erythrocyte membrane in animal hypertension,'0 as well as in red' -14 and white blood cells'5 of patients with essential hypertension or of their normotensive offspring. 16 17 Impairment of the sodium pump has been found by some workers,'5 and a deficiency in the Na+/K+ cotransport system has been described by others."' As related to hypertension, these disorders are spread throughout the body and involve arteriolar smooth muscle, which is the actual culprit. Unfortunately, blood cells, which can be easily studied, are not related at all to the muscles of the vessel wall, and the theory of abnormal membrane cation transport, although attractive, will remain speculative, until more is known about the metabolism of this tissue in essential hypertension.
Based on previous observations'8 -20 that pressure and arteriolar resistance in the pulmonary circulation are increased in systemic high blood pressure, we decided to investigate the hemodynamics of the lesser circulation in hypertension to determine whether there is a common factor that accounts for the vasoconstriction that involves the two circuits and whether intracellular calcium is involved.
Materials and Methods

Subjects
Thirty-five hospitalized men with primary arterial hypertension were investigated. Hemodynamic measurements were performed with the patients in the fasting state and supine; no premedication was given. A #7 flow-directed Swan-Ganz catheter was inserted percutaneously into an antecubital vein, floated to the pulmonary artery and advanced to the wedge position. A #6 polyethylene radiopaque catheter introduced into a brachial artery and advanced to the root of the aorta was used to monitor arterial pressure and to sample blood for cardiac output determinations. Reproducible dye-dilution curves were obtained by Gilford densitometer after rapid injection of indocyanine green dye (5 mg) into the main pulmonary artery just beyond the pulmonary valve. The area under each dye-dilution curve was measured by planimetry; cardiac output and pulmonary blood volume were calculated by the method of Hamilton et al.'' Pressures were determined with Statham P23De and P23Db strain-gauge transducers, which were balanced against atmospheric pressure. The zero reference level for pressure recordings was 5 cm below the sternal angle. Mean pressures were obtained by electronic damping. The left ventricular ejection time was measured by recording the aortic pressure tracing on an eight-channel Gould-Brush ink recorder (model 480) at a paper speed of 100 mm/sec. The interval was calculated from the mean of five consecutive beats, each read to the nearest 5 Pleural pressure was estimated by the method of Milic-Emili et al.> In brief, a rubber 2-mi esophageal balloon was introduced through the nose into the esophagus, placed 45 cm from the balloon tip to the nares, and connected to a pressure transducer through a polyethylene tube. Pleural pressure and circulatory variables were recorded simultaneously on the same recording system during quiet regular respiration. Oxygen and carbon dioxide tensions and pH were determined from an arterial blood sample drawn during quiet regular respiration. The pH was determined using the apparatus described by Siggaard-Andersen et al. 3 The Pco, was obtained with the nomogram also described by Siggaard-Andersen et al. Oxygen tension was determined with a Radiometer Po, electrode (type E 5046). The final values for each subject were the average of three measurements.
Procedures
Essential hypertension was diagnosed after admission to the hospital. The patients were given a standard hospital diet (approximately 100 mEq sodium/day) and were familiarized with the laboratory and the investigators to minimize the possible interference of emotional factors. Then, echocardiographic, hemodynamic and respiratory evaluation was performed and the circulatory response to a calcium-channel blocking agent (nifedipine, 10 mg sublingually) was tested. All of the steady-state measurements were performed when patients felt comfortable and heart rate and pressures had stabilized, at least 30 minutes after the endovascular procedures were completed. The baseline hemodynamic variables were measured 30 minutes and 5 minutes before nifedipine was given. The average of the two measurements was taken as the representative value of each subject. Aortic and pulmonary pressures and heart rate were monitored continuously during the 30 minutes before and the 120 minutes after nifedipine. Right atrial pressure, pulmonary wedge pressure and cardiac output were measured again 30, 60 and 120 minutes, respectively, after nifedipine.
The hypertensive patients were separated into two groups, according to the absence (group 1. 18 (table 1) .
The average values of the hemodynamic variables are reported in figure 1. Systemic systolic and diastolic arterial pressures were elevated to a similar degree in groups 1 and 2; since cardiac index was normal in the former and reduced in the latter, systemic vascular resistance was elevated in both groups, with a higher level in group 2. Averages of systolic, diastolic and mean pulmonary wedge pressures were relatively similar in the two hypertensive groups and significantly higher than normal; pulmonary arteriolar resistance was elevated in group I and to a larger extent in group 2. The mean velocity of circumferential fiber shortening was significantly enhanced in group 1 and reduced in group 2. Figure 2 shows the systemic vascular resistance in each hypertensive patient plotted against pulmonary arteriolar resistance. The correlation between the two variables is significant (p < 0.01).
The time course of the average percent circulatory variations from baseline induced by nifedipine in hypertensive patients is shown in figure 3 . In group 1, 30 minutes after administration of the drug, mean systemic arterial pressure was reduced by 15% and mean pulmonary arterial pressure was reduced by 6%. These reductions were mediated through a 30% decrease in systemic arteriolar resistance and a 17% decrease in pulmonary arteriolar resistance, associated with a 22% increase in cardiac index. Cardiac index increased because heart rate and stroke index increased. Although some recovery was observed, these circulatory variations were still consistently evident 120 minutes after nifedipine. In group 2, the response to calcium-ion blockade was qualitatively similar to but was characterized by a significai crease in systemic (-40%) and pulm resistance (-30%) at 30 minutes, w greater increase in cardiac index, cau duction in mean systemic ( -20%) an nary arterial pressure (-14%). The c ations after calcium blockade remain greater than in group 1 at both 60 an Discussion Pulmonary systolic and diastolic equivalent among the hypertensives a higher than in the normotensives. Car normal in group 1 and reduced in grc 0 driving pressure across the lung was augmented in both groups, pressure elevation in the pulmonary artery depended on an increased pulmonary arteriolar resistance.
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Factors of different origin are conceivably involved in a change in pulmonary arteriolar resistance: pulmonary blood flow and volume, intrathoracic and alveolar o pressures, left ventricular function, respiratory gases, autonomic nervous system, and vasomotor sub-°s tances.25-26 Respiratory gases, the pH of the blood, and the pulmonary blood volume probably were not responsible for an altered pulmonary vasomotility, as they were similar in hypertensive and control subjects. Blood flow also seems unrelated to changes in pulmonary arteriolar resistance, as it was normal in one group and reduced in the other, while resistance was elevated in both groups. Figure 3 shows that nifedipine lowers blood pressure in both the greater and the lesser circulation through vasodilatation, which involves systemic and pulmonary arterioles to a degree that, in either circuit, is proportional to the baseline levels of vascular resistance. Folkow34 emphasized the structural changes in arterial and arteriolar walls in hypertension, and pointed out that an increased wall:lumen ratio can have a progressive pressor effect, and accentuate the superimposed vascular tone adjustments correspondingly. Thereby, subtraction of the physiologic vascular tone through calcium blockade might lower blood pressure in proportion to the structural vascular changes. This interpretation might explain results in systemic circulation; whether it fits our findings in pulmonary circulation remains matter of dispute, as information on the structure of the pulmonary vessels in hypertension is lacking.
The ratios of the rate coefficients for fluxes of Na' and Ca' + across sarcolemma and for sarcolemmal sodium-calcium exchange play a critical role in the regulation of the steady-state intracellular Ca' + concentration. Factors that influence these ratios may, therefore. be important determinants of the vascular smooth fiber tension and blood pressure. Disorders in sodium and calcium permeability and transport in vessel smooth muscle and vasoconstrictor agents such as norepinephrine are examples of such factors. Norepinephrine tends to increase the mean ICa++]i through an augmented permeability of the sarcolemma to sodium35 and, perhaps, to calcium36 and by triggering the release of calcium from the sarcoplasmic reticulum. " An excessive adrenergic drive or catecholamine release as a basic mechanism for the vasoconstriction in primary high blood pressure in man might explain the antihypertensive effect of calcium-blocking agents. but this theory, although extensively debated, has never been proved.
In conclusion, failure to explain convincingly the increased pulmonary arteriolar resistance through the mechanisms that are currently considered responsible for pulmonary vasoconstriction, the significant correlation between systemic and pulmonary vascular resistance, together with the qualitatively similar response to calcium-channel blockade, consistently suggest the possibility that a common factor causes vasoconstriction in the two circuits in patients with systemic hypertension. These data do not rule out the possibility that a disordered [Ca' -i is a shared mechanism for the augmented vascular tone; however, the pathogenetic role of calcium remains to be proved.
